Susquehanna International Group’s Protagenic Therapeutics, Inc. Warrant PTIXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45K | Sell |
25,378
-24,806
| -49% | -$1.41K | ﹤0.01% | 6288 |
|
|
2025
Q1 | $376 | Sell |
50,184
-16,989
| -25% | -$127 | ﹤0.01% | 6334 |
|
|
2024
Q4 | $302 | Buy |
67,173
+20,558
| +44% | +$92 | ﹤0.01% | 6109 |
|
|
2024
Q3 | $420 | Buy |
46,615
+20,015
| +75% | +$180 | ﹤0.01% | 5558 |
|
|
2024
Q2 | $218 | Buy |
+26,600
| New | +$218 | ﹤0.01% | 5582 |
|
|
2023
Q3 | – | Sell |
-11,327
| Closed | -$379 | – | 6183 |
|
|
2023
Q2 | $379 | Sell |
11,327
-4,184
| -27% | -$140 | ﹤0.01% | 5580 |
|
|
2023
Q1 | $372 | Sell |
15,511
-8,453
| -35% | -$203 | ﹤0.01% | 5919 |
|
|
2022
Q4 | $527 | Buy |
23,964
+4,124
| +21% | +$91 | ﹤0.01% | 5707 |
|
|
2022
Q3 | $1K | Sell |
19,840
-6,879
| -26% | -$347 | ﹤0.01% | 5995 |
|
|
2022
Q2 | $4K | Buy |
+26,719
| New | +$4K | ﹤0.01% | 5596 |
|